anthropometric < anti < antiapoptotic

Facettes :

List of bibliographic references indexed by anti

Number of relevant bibliographic references: 16.

Ident.	Authors (with country if any)	Title
000102 (2011)	Samantha A. Hollingworth [Australie] ; Amanda Rush [Australie] ; Wayne D. Hall [Australie] ; Mervyn J. Eadie [Australie]	Utilization of anti‐Parkinson drugs in Australia: 1995–2009
000230 (2011)	Lucia Frau [Italie] ; Franco Borsini [Italie] ; Jadwiga Wardas [Pologne] ; Amit S. Khairnar [Italie] ; Nicoletta Schintu [Italie] ; Micaela Morelli [Italie]	Neuroprotective and anti‐inflammatory effects of the adenosine A2A receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease
000279 (2011)	José Paulo Sousa E Silva ; José S. Lobo ; Maria J. Bonifácio ; Rita Machado ; Amílcar Falcão [Portugal] ; Patrício Soares-Da-Silva	In‐vivo evaluation of prolonged release bilayer tablets of anti‐Parkinson drugs in Göttingen minipigs
000770 (2010)	Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni]	Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward
000815 (2010)	H. C. Yu ; S. F. Feng ; P. L. Chao ; A. M. Y. Lin [Taïwan]	Anti‐inflammatory effects of pioglitazone on iron‐induced oxidative injury in the nigrostriatal dopaminergic system
000A18 (2009)	You-Joung Kim [Corée du Sud] ; Hyun-Jung Park [Corée du Sud] ; Gwang Lee [Corée du Sud] ; Oh Young Bang [Corée du Sud] ; Young Hwan Ahn [Corée du Sud] ; Eunhye Joe [Corée du Sud] ; Hyun Ok Kim [Corée du Sud] ; Phil Hyu Lee [Corée du Sud]	Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti‐inflammatory action
001004 (2007)	Hyun Jung Park [Corée du Sud] ; Phil Hyu Lee [Corée du Sud] ; Young Whan Ahn [Corée du Sud] ; Yun Jung Choi [Corée du Sud] ; Gwang Lee [Corée du Sud] ; Da-Yong Lee [Corée du Sud] ; Eun S. Chung [Corée du Sud] ; Byung Kwan Jin [Corée du Sud]	Neuroprotective effect of nicotine on dopaminergic neurons by anti‐inflammatory action
001079 (2007)	M. Brandt-Christensen ; A. G. Lopez [Danemark] ; F. M. Nilsson [Danemark] ; P. K. Andersen [Danemark] ; L. V. Kessing	Depressive disorders and anti‐parkinson drug treatment: a case register study
001115 (2007)	Kenjiro Ono [Japon] ; Mie Hirohata [Japon] ; Masahito Yamada [Japon]	Anti‐fibrillogenic and fibril‐destabilizing activities of anti‐Parkinsonian agents for α‐synuclein fibrils in vitro
001765 (2003)	Orly Weinreb [Israël] ; Silvia Mandel [Israël] ; Moussa B. H. Youdim [Israël]	Gene and Protein Expression Profiles of Anti‐ and Pro‐apoptotic Actions of Dopamine, R‐Apomorphine, Green Tea Polyphenol (−)‐Epigallocatechine‐3‐gallate, and Melatonin
001A10 (2001)	Moussa B. H. Youdim [Israël] ; A. Wadia [États-Unis] ; W. Tatton [États-Unis] ; Marta Weinstock [Israël]	The Anti‐Parkinson Drug Rasagiline and Its Cholinesterase Inhibitor Derivatives Exert Neuroprotection Unrelated to MAO Inhibition in Cell Culture and in Vivo
001C43 (2000)	George A. Veech [États-Unis] ; Jameel Dennis [États-Unis] ; Paula M. Keeney [États-Unis] ; Christopher P. Fall [États-Unis] ; Russell H. Swerdlow [États-Unis] ; W. Davis Parker Jr. [États-Unis] ; James P. Bennett Jr. [États-Unis]	Disrupted mitochondrial electron transport function increases expression of anti‐apoptotic Bcl‐2 and Bcl‐XL proteins in SH‐SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress
002409 (1994)	V. Govoni [Italie] ; E. Granieri [Italie] ; M. R. Tola [Italie] ; I. Casetta [Italie] ; V. C. Monetti [Italie] ; E. Fainardi [Italie] ; E. Paolino [Italie]	Prevalence of anti‐parkinson drugs’ use in Ferrara, Northern Italy, 1988
002564 (1993)	Giovanni Diana [Italie] ; Stefania Spila Alegiani [Italie] ; Marco Fortini [Italie] ; Roberto [Italie] ; Roberto Raschetti [Italie]	Anticholinergic anti‐Parkinson drug prescription in haloperidol‐treated patients: A population‐based study
002C56 (1975)	W. Birkmayer [Autriche] ; P. Riederer [Autriche] ; H. Youdim [Autriche] ; W. Linauer [Autriche]	The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil
002D13 (1971)	Takashi Ban [Japon] ; Masakazu Hojo [Japon]	A comparative study of the effects of anti-parkinson drugs on the oxotremorine-induced EEG and muscular activities

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "anti" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "anti" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    anti
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024